Royal Bank of Canada
GOSS icon

Royal Bank of Canada’s Gossamer Bio GOSS Stock Holding History

Royal Bank of Canada’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Buy
18,521
+11,152
+151% +$3.11K ﹤0.01% 7054
2026
Q1 		$2K Buy
7,369
+1,875
+34% +$2.95K ﹤0.01% 6702
2025
Q4 		$17K Sell
5,494
-996,112
-99% -$2.84M ﹤0.01% 6140
2025
Q3 		$2.63M Buy
1,001,606
+919,407
+1,119% +$2.03M ﹤0.01% 3172
2025
Q2 		$101K Buy
82,199
+81,433
+10,631% +$88.8K ﹤0.01% 5602
2025
Q1 		$1K Sell
766
-739
-49% -$854 ﹤0.01% 6665
2024
Q4 		$1K Sell
1,505
-1,846
-55% -$1.58K ﹤0.01% 6778
2024
Q3 		$3K Sell
3,351
-262
-7% -$252 ﹤0.01% 6597
2024
Q2 		$3K Buy
3,613
+463
+15% +$346 ﹤0.01% 6655
2024
Q1 		$4K Sell
3,150
-66
-2% -$73 ﹤0.01% 6499
2023
Q4 		$3K Buy
3,216
+66
+2% +$49 ﹤0.01% 6727
2023
Q3 		$3K Sell
3,150
-215
-6% -$248 ﹤0.01% 6718
2023
Q2 		$4K Sell
3,365
-8,167
-71% -$10.2K ﹤0.01% 6732
2023
Q1 		$14K Sell
11,532
-5,714
-33% -$10.9K ﹤0.01% 6168
2022
Q4 		$37K Buy
17,246
+15,621
+961% +$129K ﹤0.01% 6054
2022
Q3 		$19K Buy
1,625
+1,115
+219% +$13.8K ﹤0.01% 6170
2022
Q2 		$4K Sell
510
-6,602
-93% -$51.2K ﹤0.01% 6720
2022
Q1 		$61K Sell
7,112
-4,538
-39% -$43.8K ﹤0.01% 5967
2021
Q4 		$132K Buy
11,650
+5,823
+100% +$69.2K ﹤0.01% 5721
2021
Q3 		$73K Sell
5,827
-52,053
-90% -$479K ﹤0.01% 5925
2021
Q2 		$470K Buy
57,880
+54,040
+1,407% +$469K ﹤0.01% 4344
2021
Q1 		$36K Buy
3,840
+1,470
+62% +$14.8K ﹤0.01% 6089
2020
Q4 		$23K Buy
2,370
+1,370
+137% +$13.5K ﹤0.01% 5996
2020
Q3 		$12K Sell
1,000
-65
-6% -$862 ﹤0.01% 5867
2020
Q2 		$14K Buy
1,065
+883
+485% +$11.1K ﹤0.01% 5716
2020
Q1 		$2K Sell
182
-7,364
-98% -$96.2K ﹤0.01% 6291
2019
Q4 		$118K Buy
7,546
+2,546
+51% +$51.3K ﹤0.01% 4997
2019
Q3 		$84K Sell
5,000
-1,967
-28% -$39.1K ﹤0.01% 4885
2019
Q2 		$154K Buy
6,967
+1,967
+39% +$37.6K ﹤0.01% 4641
2019
Q1 		$108K Buy
+5,000
New +$104K ﹤0.01% 4725

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Royal Bank of Canada's GOSS Position: Q2 2026 in Review

Royal Bank of Canada increased its Gossamer Bio (GOSS) stake by 151% in Q2 2026, buying an estimated $3.11K and bringing the position to 18,521 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #7054.

Royal Bank of Canada first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.63M in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Royal Bank of Canada held 18,521 shares of Gossamer Bio worth $3K as of Q2 2026.
  • Royal Bank of Canada bought 11,152 Gossamer Bio shares in Q2 2026, an estimated $3.11K.
  • Gossamer Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7054 holding.
  • Royal Bank of Canada first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • Royal Bank of Canada's Gossamer Bio position peaked at $2.63M in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.